which are glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog What to Make of the

The global respective SURMOUNT study program comprises four randomized controlled trials with a study duration of at least 72 weeks using the tirzepatide doses of 10 and 15 mg in the studies SURMOUNT-2 to SURMOUNT-4 and all three doses, including the 5-mg dose in SURMOUNT-1 (8285)

For example, the P5 exenatide analogue is biased to reduce the recruitment of -arrestin, resulting in better long-term hypoglycemic effects than those shown by exenatide, under the precondition that P5 has less cAMP activity

1.1% with metformin 500 mg twice daily

Available from: Novo Nordisk: Company announcements

10.1016/S0140-6736(09)61375-1

If you are comparing GLP-1 options, you may also want to read how to choose between weight loss injections